Expertise

Enno specializes in pharmaceutical, pharmacy, and medical device law. He advises pharmaceutical and medical device companies on regulatory matters throughout the entire product lifecycle, as well as on business-critical compliance issues and strategic risk management. A further focus of his practice is digital health services, telemedicine, AI systems in healthcare, and innovative healthcare delivery and platform models. He supports clients in the legally compliant design and implementation of new business models at the intersection of healthcare, digitalization and regulation.

Vita

Enno studied in Marburg and Exeter (LL.M. 2011) specializing on the German healthcare system including secondments with a Dax-rated global healthcare group and statutory health insurances. He worked at an Institute for medical law in Marburg from 2003 to 2007.

He is a lecturer in international pharmaceutical contract law in the master's program in pharmaceutical law at the Philipps University of Marburg.

Enno speaks German, English and French.

News
Radical simplification of the MDR and IVDR Article
Gleiss Lutz advises Ackermans & van Haaren on investment in DISCO Pharmaceuticals Mandate
Update on cannabis legalisation: German Federal Government to prohibit telemedical prescriptions of medical cannabis Article
Gleiss Lutz advises Sumitomo on the acquisition of Bayer's Metribuzin Solo business in Latin America, Asia-Pacific and Canada Mandate
Gleiss Lutz advises medatixx on the acquisition of mediDOK Mandate
Gleiss Lutz advises Sunshine Lake Pharma on its listing on Hong Kong Stock Exchange and privatisation of YiChang HEC Mandate

All news

Expertise

Enno specializes in pharmaceutical, pharmacy, and medical device law. He advises pharmaceutical and medical device companies on regulatory matters throughout the entire product lifecycle, as well as on business-critical compliance issues and strategic risk management. A further focus of his practice is digital health services, telemedicine, AI systems in healthcare, and innovative healthcare delivery and platform models. He supports clients in the legally compliant design and implementation of new business models at the intersection of healthcare, digitalization and regulation.

Vita

Enno studied in Marburg and Exeter (LL.M. 2011) specializing on the German healthcare system including secondments with a Dax-rated global healthcare group and statutory health insurances. He worked at an Institute for medical law in Marburg from 2003 to 2007.

He is a lecturer in international pharmaceutical contract law in the master's program in pharmaceutical law at the Philipps University of Marburg.

Enno speaks German, English and French.

News
Radical simplification of the MDR and IVDR Article
Gleiss Lutz advises Ackermans & van Haaren on investment in DISCO Pharmaceuticals Mandate
Update on cannabis legalisation: German Federal Government to prohibit telemedical prescriptions of medical cannabis Article
Gleiss Lutz advises Sumitomo on the acquisition of Bayer's Metribuzin Solo business in Latin America, Asia-Pacific and Canada Mandate
Gleiss Lutz advises medatixx on the acquisition of mediDOK Mandate
Gleiss Lutz advises Sunshine Lake Pharma on its listing on Hong Kong Stock Exchange and privatisation of YiChang HEC Mandate

All news